Phase I study of sorafenib in combination with everolimus (RAD001) in patients with advanced neuroendocrine tumors

Title
Phase I study of sorafenib in combination with everolimus (RAD001) in patients with advanced neuroendocrine tumors
Authors
Keywords
Neuroendocrine, Phase I, Sorafenib, Everolimus
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 71, Issue 5, Pages 1241-1246
Publisher
Springer Nature
Online
2013-03-08
DOI
10.1007/s00280-013-2118-9

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started